GO:0070731 cGMP transport: Mechanism, Genes, Functions

Cyclic guanosine monophosphate (cGMP) is a pivotal second messenger that regulates diverse physiological processes, including smooth muscle relaxation, phototransduction, and neuronal plasticity. The intracellular concentration of cGMP is tightly controlled not only by its synthesis via guanylate cyclases and degradation by phosphodiesterases but also by its active transport across cellular membranes. GO:0070731, cGMP transport, captures the directed movement of cGMP into, out of, or within a cell, a process essential for terminating or propagating cGMP signals. Understanding this transport mechanism is critical because it directly impacts the availability of cGMP at its effector sites, such as protein kinase G (PKG), cyclic nucleotide-gated channels, and phosphodiesterases. Research over the past three decades has identified specific ATP-binding cassette (ABC) transporters, notably ABCC5 (MRP5), as primary mediators of cGMP efflux. Studies using human and mouse erythrocyte vesicles demonstrated saturable, ATP-dependent cGMP transport, confirming an active transport mechanism. Subsequent work showed that this transport can be modulated by steroid hormones, with progesterone and testosterone inhibiting ABCC5-mediated cGMP efflux. Beyond mammals, cGMP transport has been described in Drosophila, where a cGMP-specific phosphodiesterase homologue participates in active transport, and in Arabidopsis, where cGMP modulates gene transcription and cation transport. These findings underscore the evolutionary conservation and functional importance of cGMP transport. For researchers, GO:0070731 provides a framework to study how cells regulate cGMP gradients and how dysfunction in this process contributes to disease. The term encompasses both influx and efflux mechanisms, though efflux via ABC transporters is the best-characterized route. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to deliver a research-grade overview of cGMP transport, its genetic players, regulatory mechanisms, disease relevance, and experimental strategies, including CRISPR-based models.

GO:0070731, cGMP transport, is defined by QuickGO as the directed movement of cyclic GMP (cGMP) into, out of, or within a cell. This biological process involves the translocation of cGMP across lipid bilayers, typically mediated by specific membrane transporters, and is distinct from the enzymatic synthesis or hydrolysis of cGMP. The term also includes the synonym cyclic GMP transport.

cGMP transport is fundamentally important because it determines the spatial and temporal dynamics of cGMP signaling. By actively removing cGMP from the cytoplasm, transporters such as ABCC5 prevent excessive activation of downstream effectors like PKG and cyclic nucleotide-gated channels, thereby maintaining cellular homeostasis. Dysregulation of cGMP transport has been linked to hypertension, heart failure, and cancer drug resistance, where elevated efflux reduces the efficacy of cGMP-modulating therapies. Moreover, cGMP transport in erythrocytes influences vascular tone by modulating nitric oxide bioavailability. In plants, cGMP transport participates in auxin transport and lateral root formation, highlighting its broad biological significance. Thus, understanding GO:0070731 is essential for both basic cell biology and translational medicine.

The following genes and proteins have been experimentally implicated in cGMP transport (GO:0070731) based on verified PubMed literature.

cGMP transport is regulated at multiple levels. First, the expression and activity of ABC transporters like ABCC5 are modulated by transcriptional and post-translational mechanisms. Steroid hormones, including progesterone and testosterone, directly inhibit ABCC5-mediated cGMP transport, providing a rapid regulatory mechanism. Second, cellular ATP levels influence transport capacity, as the process is energy-dependent. Third, phosphodiesterases such as PDE5 degrade cGMP, indirectly affecting the substrate pool available for transport. In plants, cGMP transport is regulated by auxin and modulates cation transport, indicating cross-talk with hormonal signaling. Additionally, nitric oxide signaling can regulate cGMP transport via adenosine A3 receptors, as shown in serotonin transport studies. These layers of regulation ensure that cGMP transport is finely tuned to physiological demands.

cGMP transport plays a critical role in vascular smooth muscle relaxation and platelet function. ABCC5-mediated cGMP efflux from erythrocytes contributes to the regulation of vascular tone by modulating nitric oxide bioavailability. Dysregulated cGMP transport has been implicated in hypertension and heart failure, where altered cGMP levels affect cardiac contractility and remodeling. Targeting cGMP transporters could provide novel therapeutic strategies for cardiovascular disorders.

Overexpression of ABC transporters such as ABCC5 and ABCC4 is associated with resistance to anticancer drugs, partly due to increased efflux of cyclic nucleotides and nucleotide analogs. cGMP transport can reduce the efficacy of cGMP-modulating chemotherapeutics, and inhibition of these transporters may sensitize cancer cells to treatment. Studies in erythrocytes and cancer cell lines have shown that steroid hormones can modulate this efflux, suggesting endocrine influences on chemoresistance.

cGMP signaling is essential for synaptic plasticity, memory, and neuronal survival. Transporters that regulate cGMP levels in the brain, such as ABCC5, may contribute to neurodegenerative conditions like Alzheimer's disease and Parkinson's disease. Additionally, adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP, linking cGMP transport to mood disorders and neuropsychiatric conditions. Further research is needed to fully elucidate these connections.

In plants, cGMP transport modulates gene transcription and cation transport in roots, influencing lateral root formation and stress responses. While not a human disease, understanding cGMP transport in plants can inform agricultural biotechnology and reveal conserved mechanisms. These studies highlight the evolutionary importance of cGMP transport in multicellular organisms.

Inside-out membrane vesicles prepared from erythrocytes or transfected cells are incubated with radiolabeled cGMP in the presence or absence of ATP. Transport is measured by filtration or rapid centrifugation. This method was pivotal in demonstrating ATP-dependent cGMP transport by ABCC5. It allows kinetic analysis and inhibitor testing, such as with progesterone.

Genome-wide CRISPR knockout libraries can be used to identify genes required for cGMP transport. Cells are exposed to a cGMP-dependent selection pressure, and sgRNAs targeting candidate transporters are enriched or depleted. This approach can uncover novel regulators beyond known ABC transporters.

Genetically encoded cGMP biosensors, such as cGES-DE5, allow real-time monitoring of intracellular cGMP dynamics. Combining these sensors with CRISPR knockouts of transporters reveals how transport shapes cGMP gradients. This method provides spatial and temporal resolution in living cells.

RNA-seq and quantitative proteomics can profile expression changes in response to cGMP transport modulation. For example, treating cells with steroid hormones alters transporter expression and cGMP levels. In plants, transcriptomic analysis of Arabidopsis roots treated with cGMP revealed changes in cation transport genes.

Researchers studying cGMP transport-related genes often need to determine whether a candidate gene is causally involved in the transport process or is merely correlated with changes in cGMP levels. CRISPR-based genome editing provides the gold standard for establishing such causal links, enabling precise knockout, point mutation, knock-in, and overexpression of transporters like ABCC5 in relevant cell models.

GO:0070731, cGMP transport, is a fundamental biological process that regulates the spatial and temporal dynamics of cyclic GMP signaling. Mediated by ATP-dependent transporters such as ABCC5, this process is conserved across species and impacts diverse physiological and pathological states, from vascular tone and neurotransmission to cancer drug resistance and plant development. Understanding the genetic and molecular mechanisms of cGMP transport requires robust experimental models, and CRISPR-based editing offers unparalleled precision for dissecting causal roles. As research advances, targeting cGMP transport may yield novel therapeutic opportunities for cardiovascular, neurological, and oncological diseases.